Genisphere and LIMR Continue Collaboration on miRNA Biomarker Development for Inflammatory Bowel Disease
13:27 EDT 10 Jul 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Genisphere
and the Lankenau
Institute for Medical Research (LIMR) will continue their
partnership on microRNA (miRNA) biomarker development for Ulcerative
Colitis (UC) and will expand the collaboration to include Crohn’...
Other Sources for this Article
Genisphere
Bob Getts, 215-996-3027
Bob_Getts@genisphere.com
or
Chempetitive
Group
Ken Li, 312-997-2436 x 109
kli@chempetitive.com
More From BioPortfolio on "Genisphere and LIMR Continue Collaboration on miRNA Biomarker Development for Inflammatory Bowel Disease"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
